Gluten Immunogenic Peptides (GIP) Point-of-Care Urine Test in Coeliac Disease Follow-up before and during the COVID-19 Lockdown in Italy
Carolina Ciacci,1 Mario Gagliardi,1 Monica Siniscalchi,1 Monica Ruotolo,1 Antonella Santonicola,1 Najla Hajji,1 Fabiana Zingone2 1Celiac Center at Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy; 2Gastroenterology Unit, Department of S...
Main Authors: | Ciacci C, Gagliardi M, Siniscalchi M, Ruotolo M, Santonicola A, Hajji N, Zingone F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-11-01
|
Series: | Clinical and Experimental Gastroenterology |
Subjects: | |
Online Access: | https://www.dovepress.com/gluten-immunogenic-peptides-gip-point-of-care-urine-test-in-coeliac-di-peer-reviewed-fulltext-article-CEG |
Similar Items
-
Verifying Diagnosis of Refractory Celiac Disease With Urine Gluten Immunogenic Peptides as Biomarker
by: María de Lourdes Moreno, et al.
Published: (2021-01-01) -
Adherence to Gluten-Free Diet Restores Alpha Diversity in Celiac People but the Microbiome Composition Is Different to Healthy People
by: Orazio Palmieri, et al.
Published: (2022-06-01) -
Dynamics of Serologic Change to Gluten in Celiac Disease Patients
by: Jack Syage, et al.
Published: (2023-12-01) -
Emerging Pharmaceutical Therapies to Address the Inadequacy of a Gluten-Free Diet for Celiac Disease
by: Martina Crepaldi, et al.
Published: (2023-12-01) -
Analytical and functional approaches to assess the immunogenicity of gluten proteins
by: Gianfranco Mamone, et al.
Published: (2023-01-01)